- Case report
- Open Access
- Open Peer Review
Laparoscopic myomectomy of a subserous pedunculated fibroid at 14 weeks of pregnancy: a case report
© Ardovino et al; licensee BioMed Central Ltd. 2011
- Received: 26 April 2011
- Accepted: 5 November 2011
- Published: 5 November 2011
Uterine leiomyomas are seen in 1.6% to 4% of pregnancies. With the increasing age of obstetric patients, more cases are being encountered during pregnancy.
We report the case of a 31-year-old Caucasian woman with acute recurrent abdominal pain due to a subserous fundic myoma, measuring 48 × 52 × 63 mm, with an implantation base of 22 × 18 mm, which was successfully treated by laparoscopy at 14 weeks of pregnancy. At a gestational age of week 40, the patient spontaneously delivered a healthy 3216 g girl baby.
As far as we know, this is the first reported case of laparoscopic myomectomy this early during a pregnancy. Our experience together with an analysis of cases reported in the literature suggests that myomectomy during pregnancy may be considered safe, but only in the hands of experienced laparoscopic surgeons. There are a few reports in the literature about laparoscopic myomectomy during the first half of pregnancy that demonstrate its feasibility in selected cases. Some technical tools could improve the procedure with a minimum of risk for the ongoing pregnancy.
- Ongoing Pregnancy
- Veress Needle
- Uterine Leiomyomas
- Laparoscopic Myomectomy
Uterine leiomyomas are seen in 1.6% to 4% of pregnancies. With the increasing age of obstetric patients, more cases are being encountered during pregnancy. The effect of leiomyomas on pregnancy depends on their number, size and location. Myomectomy is generally avoided during pregnancy because increased vascularity can lead to hemorrhagic complications that may necessitate hysterectomy, but it is indicated in some situations [1–3]. Indications for myomectomy during pregnancy include severe abdominal pain due to torsion of subserous pedunculated myomas or red degeneration not responding to medical treatment, and an increase in myoma size causing abdominal discomfort [4, 5].
There are a few reports in the literature about laparoscopic myomectomy during the first half of pregnancy that demonstrate its feasibility in selected cases [1, 6–10]. However, laparoscopic myomectomy can be considered a minimally invasive alternative to the traditional laparotomy during pregnancy, resulting in less postoperative pain and a shorter recovery time .
We report a case of acute recurrent abdominal pain due a subserous fundic myoma that was treated by laparoscopy at 14 weeks of pregnancy. Additionally, we examine some technical surgical aspects and devices, and review the international literature.
A 31-year-old, Caucasian primigravid woman was referred to our attention at 14 weeks of gestation because of acute recurrent abdominal pain localized in the right periumbilical region and not responsive to analgesic therapy. On admission she was 165 cm height, 65 kg weight with a body mass index (BMI) of 23.5. She had no fever and a normal white blood cell count.
At pelvic examination the uterus appeared bigger than expected for gestational age and irregular. A trans-abdominal sonographic scan showed the presence of an intrauterine singleton pregnancy corresponding to gestation date and a subserous fundic myoma, measuring 48 × 52 × 63 mm, with an implantation base of 22 × 18 mm. No other ultrasonographic sign related to the symptoms such as hemoperitoneum or area of degeneration in the myoma was observed. She received paracetamol and tramadol, without relief. As the acute abdominal pain symptoms suggested a possible torsion of the myoma, laparoscopic surgery was performed under general anaesthesia.
Definitive pathologic examination confirmed the diagnosis of a myoma weighing 127 g. At gestational age week 40, she spontaneously delivered a healthy baby girl weighing 3216 g.
This is the first reported case of laparoscopic myomectomy during such an early time of pregnancy (14 weeks) that we could find in the literature. Although the myoma was quite big (127 g), its position (fundic right lateral region) let us easily complete the intervention. Although postoperative adhesion development after laparoscopic myomectomy has been described in the literature and in our patient the source of pain was the adhesion, simple adhesiolysis was not contemplated. We decided to perform a complete myomectomy to eliminate the risk of red degeneration and necrosis during the ongoing pregnancy [4, 5]. We also decided not to apply an adhesion barrier over the surgical site, since data presented in the literature are still not conclusive, even if they show an encouraging safety profile .
Uterine myomas are the most frequent gynecological tumors and they are seen in 1.6% to 4% of pregnancies. Most myomas remain asymptomatic during pregnancy. Routine ultrasonography performed at this time improves the detection of these lesions and the evaluation of any possible complications. Such complications comprise spontaneous abortion, antepartum bleeding, premature rupture of membranes, preterm labor, placenta previa, post-partum bleeding and a high incidence of Caesarean deliveries .
Although controversy persists among reports of myomectomy being performed during pregnancy, there are specific clinical conditions that require this surgical procedure. These include severe abdominal pain due to torsion of subserous pedunculated myomas or red degeneration not responding to medical treatment, and an increase in myoma size causing abdominal discomfort [2, 4].
Although myomectomy during pregnancy may lead to abortion, fetal acidosis and hemorrhage, we are aware of no available published cases of post-operative abortion or fetal acidosis during laparoscopic myomectomy [2, 3]. Hemorrhage is the first complication of laparoscopic myomectomy. Although there is a high incidence of blood loss during myomectomy, there are no reported cases of conversion to open surgery or surgical delivery related to myoma resulting in uncontrolled bleeding during laparoscopy [4, 5].
Although a laparoscopic approach for uterine myomas during pregnancy is rarely described, our experience suggests that uterine myomas can be easily managed laparoscopically by an experienced surgeon in selected cases, depending on size, type and position of the fibroids.
Case reports of laparoscopic myomectomy performed during pregnancy: overview of the characteristics.
N° of myomas
Gestational week at surgery time
Lucas V et al.
Pelosi MA et al.
Sentilhes L et al.
Septic necrosis of the myometrium
Melgrati et al.
Fanfani et al.
Son et al.
The main issues regarding laparoscopic myomectomy during pregnancy were found to be the following: entry, pneumoperitoneum, electricity, uterine mobilization and myoma morcellation.
Initial access can be safely accomplished with an open (Hasson), Veress needle or optical trocar technique if the location is adjusted according to fundal height, previous incisions, and experience of the surgeon (Level III). There has been much debate regarding abdominal access in the pregnant patient with preferences toward either an open technique or Veress needle. The concern for using the Veress needle technique has largely been based on concerns about the higher likelihood of injury to the uterus or other intra-abdominal organs as fundal height increases . If the site of initial abdominal access is adjusted according to fundal height and the abdominal wall is elevated during insertion, both the Hasson technique and the Veress needle can be safely and effectively utilized .
Our case is the first report of an uncomplicated entry performed with the classic Veress needle technique. Our choice was determined by two main factors: the first one is that there was a low risk of uterine damage, since the 14-week uterine fundus raised the hypogastrium, being 4 cm under the umbilical scar. The second reason was the fact that the myoma was situated in the right iliac fossa, thus avoiding any injury during the entry .
The second main issue is pneumoperitoneum induction, as the pneumoperitoneum using CO2 may irritate the uterine tissues and increase the risk of acidosis to the fetus.
The potential effects of CO2 insufflation on the pregnant patient and her fetus have led to apprehension over its use. The pulmonary effects of pneumoperitoneum in the pregnant patient and the potential risk for acidosis to the fetus have caused concern and have led some investigators to develop alternative approaches of gasless laparoscopy  but in only one case was a gasless surgery performed . In our case the insufflation pressure was set at 10 mmHg from the beginning of the intervention. In our 20 years of laparoscopic experience this reduces postoperative pain, and in our case this method lowered the potential effects of CO2 insufflation on the patient and her fetus, with a decreased acidosis and abortion risk . Fetal acidosis and associated fetal instability in CO2 pneumoperitoneum have been documented in animal studies, although no long-term effects from these changes have been identified [3, 12]. Fetal acidosis with insufflation has not been documented in the human fetus, but concerns over potential detrimental effects of acidosis have led to the recommendation of maternal CO2 monitoring [3, 12]. Initially, there was debate over maternal blood gas monitoring of arterial carbon dioxide (PaCO2) versus end-tidal carbon dioxide (EtCO2) monitoring, but the less invasive capnography has been demonstrated to reflect maternal acid/base status adequately in humans [3, 12]. Several large studies have documented the safety and efficacy of EtCO2 measurements in pregnant women  making routine blood gas monitoring unnecessary .
Electricity is needed during a laparoscopic myomectomy in order to gain an optimum hemostasis. In case of myomectomy during pregnancy all the authors agree on the use of bipolar electricity to minimize any possible injury to the fetus [1, 6–10]. In our case, after positioning a Monocryl 1 no- needle suture, we enucleated the myoma with the bipolar Plasmaspatula, thus avoiding sparking phenomena associated with monopolar energy sources that may endanger the fetus or displaced bowel [3, 10]. This is a bipolar electrosurgical device designed to deliver high current and very low voltage to tissue. Tissue impedance is continuously monitored by the instrument, and energy delivery is adjusted accordingly. This system delivers electrosurgical energy through a series of rapid pulses, thereby allowing the tissue to cool briefly and limiting the heating of adjacent tissue. Protein in the vessel walls is denatured and forms a coagulum, which occludes the lumen .
Therefore, the cut of the myoma was at the level of the large base right up the suture. The minimum residual tissue of the myoma became completely ischemic, thus avoiding any problem for the patient. This method of removing the myoma lets the surgeon cut far away from the myometrium, thus avoiding a possible uterine contraction, with consequent high risk for abortion.
Uterine mobilization may represent a challenge for the surgeon, as it is not possible to use a uterine manipulator during pregnancy. The size of the myoma itself could also represent another challenge. The largest myoma removed by laparoscopy weighed 1500 g .
Myoma morcellation may lead to severe uterine damage, which could be harmful for the ongoing pregnancy. A transumbilical morcellation is described in only one of the reported cases ; indeed, transumbilical morcellation is well described in laparoscopic gynecological surgery. The present morcellation technique, performed by using a 3 mm, 10 degree telescope introduced in the left 5 mm trocar, lets the surgeon take a comfortable position, and, in addition, this method keeps the morcellator blade far away from the gravid uterus. This is a clear advantage in the situation of pregnancy, where it is impossible to manipulate the uterus. Additionally, the telescope introduced in the left 5 mm trocar allows optimal spatial vision.
In the end, the use of a mininvasive technique with two 5 mm ancillary trocars resulted in minimal damage to the abdominal organs and a high aesthetic acceptability. In our recent experience the use of two 5 mm ancillary trocars for laparoscopic myomectomy is a good approach for the surgeon and has a high aesthetic acceptability for the woman. It lets the surgeon work without particular problems and allows the easy use of either extra- or intra-corporeal knots.
Our experience, together with the analysis of literature, suggests that laparoscopic myomectomy during pregnancy may be considered safe in selected cases, even in an early stage, but only in the hands of experienced laparoscopic surgeons.
Safety and pregnancy risk cannot be concluded on the basis of six case reports, only five of which have pregnancy outcome data. Further investigations are needed to improve and better define safety and feasibility of laparoscopic myomectomy during pregnancy.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Fanfani F, Rossitto C, Fagotti A, Rosati P, Gallotta V, Scambia G: Laparoscopic myomectomy at 25 weeks of pregnancy: case report. J Minim Invasive Gynecol. 2010, 17: 91-93. 10.1016/j.jmig.2009.08.004.View ArticlePubMedGoogle Scholar
- Lolis DE, Kalantaridou SN, Makrydimas G, Sotiriadis A, Navrozoglou I, Zikopoulos K, Paraskevaidis EA: Successful myomectomy during pregnancy. Hum Reprod. 2003, 18: 1699-1702. 10.1093/humrep/deg318.View ArticlePubMedGoogle Scholar
- Guidelines Committee of the Society of American Gastrointestinal and Endoscopic Surgeons, Yumi H: Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc. 2008, 22: 849-861.View ArticleGoogle Scholar
- Bonito M, Gulemì L, Basili R, Roselli D: Myomectomy during the first and second trimester of pregnancy. Clin Exp Obstet Gynecol. 2007, 34: 149-150.PubMedGoogle Scholar
- Agdi M, Tulandi T: Minimally invasive approach for myomectomy. Semin Reprod Med. 2010, 28: 228-234. 10.1055/s-0030-1251479.View ArticlePubMedGoogle Scholar
- Melgrati L, Damiani A, Franzoni G, Marziali M, Sesti F: Isobaric (gasless) laparoscopic myomectomy during pregnancy. J Minim Invasive Gynecol. 2005, 12: 379-381. 10.1016/j.jmig.2005.05.012.View ArticlePubMedGoogle Scholar
- Pelosi MA, Pelosi MA, Giblin S: Laparoscopic removal of a 1500g syptomatic myoma during the second trimester of pregnancy. J Am Assoc Gynecol Laparosc. 1995, 2: 457-462. 10.1016/S1074-3804(05)80070-2.View ArticlePubMedGoogle Scholar
- Sentilhes L, Sergent F, Verspyck E, Gravier A, Roman H, Marpeau L: Laparoscopic myomectomy during pregnancy resulting in septic necrosis of the myometrium. BJOG. 2003, 110: 876-878. 10.1111/j.1471-0528.2003.03045.x.View ArticlePubMedGoogle Scholar
- Lucas V, Barjot P, Allouche C, Six T, von Theobald P, Lévy G: Surgical laparoscopy and pregnancy. Eight cases. J Gynecol Obstet Biol Reprod (Paris). 1994, 23: 914-917. In FrenchGoogle Scholar
- Son CE, Choi JS, Lee JH, Jeon SW, Bae JW, S Seo S: A case of laparoscopic myomectomy performed during pregnancy for subserosal uterine myoma. J Obstet Gynaecol. 2011, 31: 180-181. 10.3109/01443615.2010.538774.View ArticlePubMedGoogle Scholar
- Fossum GT, Silverberg KM, Miller CE, Diamond MP, Holmdahl L: Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertil Steril. 2011, 96: 487-491. 10.1016/j.fertnstert.2011.05.081.View ArticlePubMedGoogle Scholar
- Jackson H, Granger S, Price R, Rollins M, Earle D, Richardson W, Fanelli R: Diagnosis and laparoscopic treatment of surgical diseases during pregnancy: an evidence-based review. Surg Endosc. 2008, 22: 1917-1927. 10.1007/s00464-008-9989-6.View ArticlePubMedGoogle Scholar
- Newcomb WL, Hope WW, Schmelzer TM, Heath JJ, Norton HJ, Lincourt AE, Heniford BT, Iannitti DA: Comparison of blood vessel sealing among new electrosurgical and ultrasonic devices. Surg Endosc. 2009, 23: 90-96. 10.1007/s00464-008-9932-x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.